Bicycle therapeutics to participate in the oppenheimer 34th annual healthcare life sciences conference

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq:bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in a fireside chat at the oppenheimer 34th annual healthcare life sciences conference on february 14, 2024, at 10 a.m. et. a live webcast of the fireside chat will be accessible from the investor section of the compan.
BCYC Ratings Summary
BCYC Quant Ranking